Papillary Serous Adenocarcinoma, also known as papillary serous cystadenocarcinoma, is related to fallopian tube adenocarcinoma and hereditary breast cancer. An important gene associated with Papillary Serous Adenocarcinoma is MIR509-1 (MicroRNA 509-1), and among its related pathways/superpathways are Primary ovarian insufficiency and Signaling by ERBB4. The drugs Temsirolimus and Sirolimus have been mentioned in the context of this disorder. Affiliated tissues include lymph node and ovary, and related phenotypes are Decreased viability in pancreas lineage and neoplasm